SEC Tracker
Get the app

GT Biopharma GTBP

GT Biopharma to hold special meeting on Nov 11

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Nov 11, 2026
  2. Proposals to amend charter and increase authorized shares
  3. Vote on issuance of 19.99%+ of common stock
  4. Proxy materials mailed on Oct 13, 2026

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when GT Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biovie BIVI public float $8M, Dec 31, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025